News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,301 Results
Type
Article (14755)
Company Profile (68)
Press Release (268475)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (101524)
Career Advice (468)
Deals (15523)
Drug Delivery (102)
Drug Development (37006)
Employer Resources (51)
FDA (6476)
Job Trends (6289)
News (151519)
Policy (14214)
Tag
2025 Best Places to Work (7)
2026 Best Places to Work (13)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
40 Under 40 (2)
Academia (470)
Accelerated approval (33)
ADA (11)
Adcomms (9)
Allergies (117)
Alliances (23387)
ALS (87)
Alzheimer's disease (591)
Antibody-drug conjugate (ADC) (240)
Approvals (6936)
Artificial intelligence (357)
ASCO (114)
Autoimmune disease (118)
Automation (26)
Bankruptcy (158)
Belgium (6)
Best Places to Work (4387)
BIO (26)
Biologics (49)
BIOSECURE Act (9)
Biosimilars (199)
BioSpace Insights (72)
Biotechnology (30)
Bispecific (14)
Bladder cancer (61)
Brain cancer (45)
Breast cancer (254)
Cancer (2099)
Cardiovascular disease (250)
Career advice (430)
Career pathing (15)
CAR-T (81)
CDC (11)
CDMO (101)
Celiac Disease (1)
Cell therapy (234)
Cervical cancer (25)
Clinical research (33363)
Collaboration (1147)
Commercialization (37)
Company closure (3)
Compensation (483)
Complete response letters (54)
COVID-19 (800)
CRISPR (68)
CRO (4)
C-suite (860)
Cystic fibrosis (68)
Data (3292)
Decentralized trials (2)
Denatured (19)
Depression (68)
Dermatology (41)
Diabetes (200)
Diagnostics (1538)
Digital health (19)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (215)
Drug pricing (126)
Drug shortages (16)
Duchenne muscular dystrophy (119)
Earnings (35074)
Editorial (25)
Employer branding (4)
Employer resources (47)
ESMO (122)
Events (40842)
Executive appointments (707)
Eye disease (4)
FDA (8250)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (4)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (668)
Gene editing (104)
Generative AI (38)
Gene therapy (240)
GLP-1 (533)
Government (1457)
Grass and pollen (4)
Guidances (178)
Healthcare (3704)
Hematology (77)
HIV (23)
Huntington's disease (16)
Idiopathic pulmonary fibrosis (4)
IgA nephropathy (72)
Immunology and inflammation (103)
Immuno-oncology (47)
Indications (139)
Infectious disease (920)
Inflammatory bowel disease (98)
Inflation Reduction Act (7)
Influenza (31)
Intellectual property (169)
Interviews (59)
IPO (5958)
IRA (33)
Job creations (2065)
Job search strategy (378)
JPM (29)
Kidney cancer (19)
Kidney disease (62)
Labor market (50)
Layoffs (226)
Leadership (14)
Legal (3467)
Licensing (82)
Liver cancer (27)
Longevity (18)
Lung cancer (299)
Lung diease (5)
Lymphoma (187)
Machine learning (17)
Management (18)
Manufacturing (769)
Marketing (21)
MASH (107)
Medical affairs (3)
Medical device (1334)
Medtech (1361)
Melanoma (58)
Mergers & acquisitions (10210)
Metabolic disorders (672)
Middle East (1)
mRNA (81)
Multiple sclerosis (74)
Multispecific (1)
NASH (15)
Netherlands (7)
Neurodegenerative disease (146)
Neuropsychiatric disorders (57)
Neuroscience (1257)
Neurotech (2)
NextGen: Class of 2026 (1588)
Non-profit (619)
Now hiring (31)
Obesity (345)
Opinion (158)
Ovarian cancer (83)
Pain (169)
Pancreatic cancer (86)
Parkinson's disease (130)
Partnered (15)
Patents (348)
Patient advocacy (1)
Patient recruitment (237)
Patient selection (33)
Peanut (18)
People (30840)
Peptides (19)
Pharmaceutical (34)
Pharmacy benefit managers (20)
Phase 1 (8607)
Phase 2 (14066)
Phase 3 (12782)
Pipeline (5245)
Policy (167)
Postmarket research (1407)
Preclinical (3469)
Press Release (25)
Prostate cancer (135)
Psychedelics (32)
Radioligand (1)
Radiopharmaceuticals (194)
Rare diseases (611)
Real estate (2674)
Recruiting (19)
Regenerative medicine (7)
Regulatory (11987)
Reports (24)
Research institute (588)
Resumes & cover letters (55)
Rett syndrome (18)
RNA editing (10)
RSV (29)
Saudi Arabia (1)
Schizophrenia (105)
Series A (134)
Series B (75)
Series C (1)
Service/supplier (1)
Sickle cell disease (68)
Special edition (15)
Spinal muscular atrophy (86)
Sponsored (13)
Startups (1665)
State (2)
Stem cells (2)
Stomach cancer (8)
Substance use disorders (7)
Supply chain (78)
Switzerland (13)
Tariffs (72)
The Weekly (57)
Vaccines (317)
Venture capital (57)
Weight loss (193)
Wet AMD (4)
Women's health (69)
Worklife (5)
Date
Today (12)
Last 7 days (220)
Last 30 days (1202)
Last 365 days (10695)
2026 (9834)
2025 (10761)
2024 (12510)
2023 (14287)
2022 (19615)
2021 (20108)
2020 (19065)
2019 (14902)
2018 (11721)
2017 (13910)
2016 (13136)
2015 (15501)
2014 (12449)
2013 (10626)
2012 (11415)
2011 (11964)
2010 (10938)
Location
Africa (328)
Alabama (25)
Alaska (1)
Arizona (111)
Arkansas (4)
Asia (21686)
Australia (2792)
California (4738)
Canada (2141)
China (961)
Colorado (210)
Connecticut (208)
Delaware (206)
Europe (42900)
Florida (898)
Georgia (90)
Hawaii (2)
Idaho (11)
Illinois (549)
India (105)
Indiana (382)
Iowa (3)
Japan (459)
Kansas (93)
Kentucky (23)
Louisiana (8)
Maine (2)
Maryland (585)
Massachusetts (3817)
Michigan (59)
Minnesota (245)
Mississippi (2)
Missouri (41)
Montana (9)
Nebraska (8)
Nevada (26)
New Hampshire (9)
New Jersey (2132)
New Mexico (7)
New York (1359)
North Carolina (873)
North Dakota (2)
Northern California (2296)
Ohio (117)
Oklahoma (6)
Oregon (17)
Pennsylvania (1022)
Puerto Rico (23)
Rhode Island (19)
South America (510)
South Carolina (16)
Southern California (2108)
Tennessee (84)
Texas (663)
United States (18717)
Utah (78)
Vermont (1)
Virginia (252)
Washington D.C. (42)
Washington State (349)
West Virginia (1)
Wisconsin (78)
Wyoming (2)
283,301 Results for "mallinckrodt pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
Both Mallinckrodt and Endo have previously declared bankruptcy, linked to opioid-related lawsuits.
March 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
November 10, 2025
·
7 min read
Press Releases
Mallinckrodt Reports Third Quarter 2025 Financial Results
November 10, 2025
·
26 min read
Mergers & Acquisitions
Mallinckrodt Offloads Therakos Photopheresis Business to CVC Capital Partners for $925M
The specialty pharmaceutical company has twice filed for bankruptcy in recent years, driven by opioid-related litigation. Mallinckrodt’s deal with CVC will allow it to pay off more than half of its net debt.
August 6, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
November 10, 2025
·
11 min read
Press Releases
Mallinckrodt and Endo Shareholders Approve Combination to Create a Global, Scaled, Diversified Pharmaceuticals Leader
June 16, 2025
·
13 min read
Press Releases
Mallinckrodt Names Leslie Donato to Board of Directors
August 5, 2025
·
3 min read
Press Releases
Mallinckrodt plc to Report Third Quarter 2025 Financial Results on November 10, 2025
October 24, 2025
·
2 min read
Press Releases
Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
September 23, 2025
·
4 min read
Press Releases
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
August 6, 2025
·
3 min read
1 of 28,331
Next